0000-0002-2763-579X About
Dr Goverdhan Lanka worked as a postdoctoral research fellow (DBT-RA2) in the Department of Pharmacy, BITS-Pilani Hyderabad Campus, for two years from 2021 to 2023. He received his M.Sc. (Organic Chemistry) degree in 2012 and was awarded his PhD in Chemistry from Osmania University in 2020. To date, he has published about 16 research articles. His research interests are Computer-Aided Drug Design (CADD), molecular modelling, theoretical organic chemistry, and in silico identification of new potential inhibitors for cancer, neurodegeneracy, and microbial diseases against various drug targets. To date, he has 3 years and 6 months of teaching experience in organic chemistry (PG), engineering chemistry (UG), PUC Chemistry (+II) as a teaching faculty.
Employment
-
BITS-Pilani Hyderabad Campus Postdoctoral Research Associate2021 - 2023
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- Pharmacophore modeling, 3D-QSAR, and MD simulation-based overture for the discovery of new potential HDAC1 inhibitors Save
- Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approaches Save
- Identification of potential antiviral lead inhibitors against SARS-CoV-2 main protease: Structure-guided virtual screening, docking, ADME, and MD Simulation based approach Save
- Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors Save
- Fragment-based structural exploration and chemico-biological interaction study of HDAC3 inhibitors through non-linear pattern recognition, chemical space, and binding mode of interaction analysis Save
- Synthesis and Molecular Docking Study of Novel Pyrazole-Integrated 1,3,4-Oxadiazole Derivatives as Potential Cyclin-Dependent Kinase 2 Inhibitors Save
- Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors: a cross-validated approach of ligand-based and structure-based molecular modeling studies Save
- Targeting tribbles homolog 3 (TRIB3) protein against type 2 diabetes for the identification of potential inhibitors by in silico screening Save
- Targeting tribbles homolog 3 (TRIB3) protein against type 2 diabetes for the identification of potential inhibitors by in silico screening Save
- Glide Docking, Autodock, Binding Free Energy and Drug-Likeness Studies for Prediction of Potential Inhibitors of Cyclin-Dependent Kinase 14 Protein in Wnt Signaling Pathway Save